How Medshield offers its members value, affordability and quality healthcare

SPONSORED | Value is the measure of a medical scheme that prioritises its members

US biopharma AbbVie to buy Botox maker Allergan for $63bn

Deal broadens product offerings amid growing pressure on drug prices

Novartis’s top-selling medicine is safe from generics — for now

US consumers lose out after judge stops rivals from making cheaper versions of multiple sclerosis drug Gilenya

Icon’s e-Auth tool gives cancer patients real-time access to life-saving treatments

SPONSORED | Icon's evidence-based protocols save medical schemes time and money

Life Healthcare bids adieu to India

SA private health group sells its 49.7% stake in Max Healthcare after a disappointing five years in which it made no profit

Life Healthcare raises R3.7bn through Indian divestment

Private hospital group sells 49.7% stake in Max Healthcare Institute to Radiant Life Care

Cash-strapped middle classes cannot afford medical aid, warns Discovery

Discovery Health's Jonathan Broomberg says net membership growth was just 2% in the year to September

Future of SA private healthcare is looking ill, warns Icon Group

SPONSORED | Value-based healthcare will provide a much-needed shot in the arm, group's latest research shows

Sanofi links with Google in using AI to improve health care

The french pharmaceutical company plans to use artificial intelligence and deep analytics tools to sift through its data to find better treatments

GlaxoSmithKline steps up pace of bringing new drugs to market

Fierce competition from US and Chinese rivals is forcing Britain’s largest drugmaker to rush to get its products out ahead of challengers

Philips upbeat as patients warm to sharing data with doctors

Health technology company expects sales at its digital care business to grow in 2019

Struggling Ascendis aims to have new CEO within three months

Shares in the troubled maker of Bettaway vitamins have slumped on debt concerns and forced share sales by a former director

Medical device industry opposes Discovery Health’s mooted fees

SA Medical Technology Industry Association warns the move could push up products prices

WATCH: Why Life Healthcare’s profit declined

Life Healthcare CEO Shrey Viranna talks to Business Day TV about the group’s interim financial performance

Life Healthcare weighs up its business in Poland

Polish operations highly vulnerable to tariff cuts

Sale of Aspen’s infant milk business to go through on Friday

Key to the Lactalis deal going through was approval by regulators in New Zealand, who gave the transaction the green light only on May 17

Published by Tiso Blackstar and distributed with the Financial Mail on the last Thursday of every month except December and January.